Quick Asked: Iteos Therapeutics Sa Contact Us?
Last update: 28 Mar, 2024 
128 Views
What is iteos therapeutics? Cancer Immunotherapies by Design™ iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients .What is icteos therapeutics? Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients.How much cash runway does iteos therapeutics have? A company's cash runway is calculated by piding its cash hoard by its cash burn. When iTeos Therapeutics last reported its balance sheet in June 2020, it had zero debt and cash worth US$137m. Looking at the last year, the company burnt through US$22m. Therefore, from June 2020 it had 6.2 years of cash runway.What is the value of the iteos 448 trial? EOS-448 is currently in phase I for advanced solid tumours with a randomised PD-1 combination study planned for 2022 iTeos to receive a $625 million upfront payment in addition to potential milestones, and royalty payments on ex-US sales GSK and iTeos will co-commercialise and share profits in the Read more
Listing Results Iteos Therapeutics Sa Contact Us? Question Answers
ITeos Therapeutics SA Information iTeos Therapeutics SA
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of the tumor microenvironment and immunosuppressive pathways to design novel product candidates with an aim to improve ...